title: Coccidioidomycosis diagnosed in South Carolina.
abstract: Primary care physicians in the Eastern United States rarely consider coccidioidomycosis in the differential diagnosis of pulmonary infections or febrile illnesses. However, the mobility of the population mandates consideration of this diagnosis, particularly in patients with fever and cough that do not resolve rapidly and in patients with adenopathy on chest radiography. In this report, we describe two unrelated cases encountered during a single week in a South Carolina internal medicine practice. These cases highlight the importance of obtaining travel histories from patients with atypical pulmonary infections. Early consideration of coccidioidomycosis confers several benefits, including allaying patient anxiety by more timely diagnosis, minimizing the empiric use of antibiotics, and reducing the need for extensive and possibly invasive diagnostic testing.
authors.affiliation: Department of Medicine, University of South Carolina School of Medicine, Columbia, SC 29203, USA.
authors.forename: J Blake
authors.initials: JB
authors.lastname: Long
authors.forename: Allan S
authors.initials: AS
authors.lastname: Brett
authors.forename: Joseph A
authors.initials: JA
authors.lastname: Horvath
mesh_terms: D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use; D003045:Coccidioides / Q000302:isolation & purification; D003047:Coccidioidomycosis / Q000175:diagnosis* / Q000188:drug therapy; D003371:Cough / Q000382:microbiology; D003937:Diagnosis, Differential; D019353:Endemic Diseases; D005334:Fever / Q000382:microbiology; D015725:Fluconazole / Q000627:therapeutic use; D006261:Headache / Q000382:microbiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D013022:South Carolina; D014195:Travel
chemical_list: D000935:Antifungal Agents; D015725:Fluconazole